Medicine Against Prostate Cancer Drugs Bicalutamide CAS: 90357-06-5 antiandrogens - USD154.00

Product Name Bicalutamide
CAS 90357-06-5
MF C18H14F4N2O4S
MW 430.37
Purity 99.50%
Grade Pharmaceutical Grade
Appearance White Powder
Indications Used in the treatment of advanced prostate cancer.
Medicine Against Prostate Cancer Drugs Bicalutamide CAS: 90357-06-5 Antiandrogens

Medicine Against Prostate Cancer Drugs Bicalutamide CAS: 90357-06-5 Antiandrogens
Bicalutamide is a non-steroidal androgen antagonist, which competes androgen receptor with the androgen, blocks cellular uptake of androgen, and inhibits the binding of androgens to the target organ. It binds with the androgen receptor that forms receptor complex, which enters the nucleus and combined with the nucleoprotein, consequently inhibiting tumor cell growth. It can be as a first-line drug for palliative treatment of advanced prostate cancer.
Application
Bicalutamide is used to treat prostate cancer that has spread to other areas of the body. It is used in combination with hormone treatment. This medication works by blocking the action of male hormones in the prostate, slowing growth of the tumors.
Bicalutamide is widely metabolized in the liver. Data show that patients with severe liver damage may slow down drug clearance, which may lead to accumulation. So the patients with moderate and severe liver injury should use it with caution.
The patients may appear liver changes by using it, so it should be considered regular liver function tests. The main changes generally appear within the first 6 months of treatment using this product.